NEW YORK – Grail has entered into a research collaboration with nonprofits the Whitman-Walker Institute and Cancer Support Community (CSC) to advance health equity in cancer screening through the use of multi-cancer early detection (MCED) testing in diverse patient populations, the partners said on Wednesday.
The collaborative study, called INCLUDE (implementation and navigation of cancer liquid biopsy to understand diverse patient experiences), will conduct community outreach to build awareness of and increase early cancer screening, focusing on groups that have been historically underrepresented in clinical care and research.
Eligible individuals will be invited by Whitman-Walker, which focuses on LGBTQ health, research, education, and policy, to participate in the study being conducted in collaboration with CSC, a global nonprofit that aims to ease cancer burdens and barriers through community support, education, and advocacy.